Back to Screener

Healthcare

Paradigm Biopharmaceuticals Limited(PBIGF)

Live Price

Offline

$0.1272

+0.00% today

1Y Change

-50.51%

Window

Jun 27, 2025 โ†’ Jun 25, 2026

Market Cap
$70.00M
Revenue Growth
-20.8%
EPS Growth
+70.2%
Dividend Yield
0.0%

Coverage: 253 bars ยท Jun 27, 2025 โ†’ Jun 25, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Paradigm Biopharmaceuticals Limited (PBIGF) is a Healthcare stock with a market cap of $70.00M and listed on OTC. The stock last traded around $0.13 and down 50.5% across the available one-year price window (Jun 27, 2025 โ†’ Jun 25, 2026). Baseline metrics include revenue growth of -20.8%, EPS growth of +70.2%, a dividend yield of 0.0%. What stands out right now is revenue -20.8%, EPS +70.2%, free cash flow +75.7% with operating margin -63782.8% and ROIC -493.0%. Valuation already assumes a fairly strong business story at price/sales 1193.4. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines PBIGF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

PBIGF vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

PBIGF

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

PBIGF Max Drawdown

-69.90%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for PBIGF and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Next earningsAug 21, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
Aug 21, 26
TBD
โ€”
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Aug 21
โ€”
Feb 26, 26
-0.04
Est โ€”
โ€”
16.8B
Est โ€”
โ€”
Feb 26
โ€”
Apr 29, 25
โ€”
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Apr 29
โ€”
Feb 26, 25
-0.01
Est โ€”
โ€”
5.2B
Est โ€”
โ€”
Feb 26
โ€”
Oct 30, 24
-0.01
Est โ€”
โ€”
5.7B
Est โ€”
โ€”
Oct 30
โ€”
Aug 30, 24
-0.01
Est โ€”
โ€”
43.9B
Est โ€”
โ€”
Aug 30
โ€”
Apr 29, 24
-0.01
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Apr 29
โ€”
Mar 21, 24
-0.11
Est โ€”
โ€”
866.7B
Est โ€”
โ€”
Mar 21
โ€”
Jan 30, 24
-0.05
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Jan 30
โ€”
Jun 30, 23
-0.02
Est โ€”
โ€”
27.9B
Est โ€”
โ€”
Jun 30
โ€”
Mar 31, 23
-0.02
Est โ€”
โ€”
14.1B
Est โ€”
โ€”
Mar 31
โ€”
Feb 26, 23
-0.04
Est โ€”
โ€”
1.5B
Est โ€”
โ€”
Feb 26
โ€”
Dec 31, 22
-0.04
Est โ€”
โ€”
1.6B
Est โ€”
โ€”
Dec 31
โ€”
Aug 25, 22
-0.02
Est โ€”
โ€”
12.8B
Est โ€”
โ€”
Aug 25
โ€”
Jun 30, 22
-0.04
Est โ€”
โ€”
23.4B
Est โ€”
โ€”
Jun 30
โ€”
Feb 23, 22
-0.04
Est โ€”
โ€”
16.4B
Est โ€”
โ€”
Feb 23
โ€”
Dec 31, 21
-0.08
Est โ€”
โ€”
32.8B
Est โ€”
โ€”
Dec 31
โ€”
Aug 26, 21
-0.02
Est โ€”
โ€”
7.8B
Est โ€”
โ€”
Aug 26
โ€”
Jun 30, 21
-0.04
Est โ€”
โ€”
15.4B
Est โ€”
โ€”
Jun 30
โ€”
Feb 23, 21
-0.03
Est โ€”
โ€”
196.4B
Est โ€”
โ€”
Feb 23
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the market calendar